
USD
$0.00
(0.00%
)At Close (As of Dec 15, 2025)
$33.26B
Market Cap
23.11
P/E Ratio
0.75
EPS
$24.41
52 Week High
$13.85
52 Week Low
CONSUMER DEFENSIVE
Sector
| Field | Value (USD) |
|---|---|
| Total Assets | $26B |
| Total Current Assets | $5.5B |
| Cash And Cash Equivalents At Carrying Value | $1.1B |
| Cash And Short Term Investments | $1.1B |
| Inventory | $1.6B |
| Current Net Receivables | $2.7B |
| Total Non Current Assets | $20B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $8.5B |
| Intangible Assets Excluding Goodwill | $8.5B |
| Goodwill | $8.8B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $205M |
| Other Non Current Assets | - |
| Total Liabilities | $16B |
| Total Current Liabilities | $5.7B |
| Current Accounts Payable | $2.3B |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.6B |
| Total Non Current Liabilities | $10B |
| Capital Lease Obligations | $225M |
| Long Term Debt | $6.9B |
| Current Long Term Debt | $1.6B |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $8.7B |
| Other Current Liabilities | $1.7B |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $9.7B |
| Treasury Stock | - |
| Retained Earnings | -$93M |
| Common Stock | $19M |
| Common Stock Shares Outstanding | $1.9B |
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-11-12 |
| Declaration Date | 2025-10-29 |
| Record Date | 2025-11-12 |
| Payment Date | 2025-11-26 |
| Amount | 0.2075 |
Sector: CONSUMER DEFENSIVE
Industry: HOUSEHOLD & PERSONAL PRODUCTS
Kenvue Inc. is a prominent player in the consumer health sector, offering a wide array of over-the-counter and personal care products designed to enhance well-being. With a portfolio of well-established brands, the company is committed to innovation and sustainability, positioning itself to thrive in a health-conscious marketplace. Utilizing its vast global reach and deep consumer insights, Kenvue is well-equipped to capitalize on emerging health trends, making it an attractive investment opportunity for institutional investors aiming to diversify within the healthcare domain.